Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Itm2a expression marks periosteal skeletal stem cells that contribute to bone fracture healing
Wenhui Xing, Heng Feng, Bo Jiang, Bo Gao, Jiping Liu, Zaiqi Xie, Yazhuo Zhang, Xuye Hu, Jun Sun, Matthew B. Greenblatt, Bo O. Zhou, Weiguo Zou
Wenhui Xing, Heng Feng, Bo Jiang, Bo Gao, Jiping Liu, Zaiqi Xie, Yazhuo Zhang, Xuye Hu, Jun Sun, Matthew B. Greenblatt, Bo O. Zhou, Weiguo Zou
View: Text | PDF
Research Article Bone biology

Itm2a expression marks periosteal skeletal stem cells that contribute to bone fracture healing

  • Text
  • PDF
Abstract

The periosteum contains skeletal stem/progenitor cells that contribute to bone fracture healing. However, the in vivo identity of periosteal skeletal stem cells (P-SSCs) remains unclear, and membrane protein markers of P-SSCs that facilitate tissue engineering are needed. Here, we identified integral membrane protein 2A (Itm2a) enriched in SSCs using single-cell transcriptomics. Itm2a+ P-SSCs displayed clonal multipotency and self-renewal and sat at the apex of their differentiation hierarchy. Lineage-tracing experiments showed that Itm2a selectively labeled the periosteum and that Itm2a+ cells were preferentially located in the outer fibrous layer of the periosteum. The Itm2a+ cells rarely expressed CD34 or Osx, but expressed periosteal markers such as Ctsk, CD51, PDGFRA, Sca1, and Gli1. Itm2a+ P-SSCs contributed to osteoblasts, chondrocytes, and marrow stromal cells upon injury. Genetic lineage tracing using dual recombinases showed that Itm2a and Prrx1 lineage cells generated spatially separated subsets of chondrocytes and osteoblasts during fracture healing. Bone morphogenetic protein 2 (Bmp2) deficiency or ablation of Itm2a+ P-SSCs resulted in defects in fracture healing. ITM2A+ P-SSCs were also present in the human periosteum. Thus, our study identified a membrane protein marker that labels P-SSCs, providing an attractive target for drug and cellular therapy for skeletal disorders.

Authors

Wenhui Xing, Heng Feng, Bo Jiang, Bo Gao, Jiping Liu, Zaiqi Xie, Yazhuo Zhang, Xuye Hu, Jun Sun, Matthew B. Greenblatt, Bo O. Zhou, Weiguo Zou

×

Figure 4

Itm2a+ P-SSCs generate osteoblasts, chondrocytes, and marrow stromal cells upon injury.

Options: View larger image (or click on image) Download as PowerPoint
Itm2a+ P-SSCs generate osteoblasts, chondrocytes, and marrow stromal cel...
(A) Experimental design for tamoxifen (Tam) induction, the bone fracture model, and tissue analysis. (B) Representative confocal images of Itm2a lineage cells (ZsGreen+) at the uninjured periosteum (left) and femoral fracture day-3 callus (right) in sections from Itm2a-CreER R26-Ai6 mice. Scale bar: 100 μm. (C) Representative 7 dpf confocal images of Itm2a lineage cells (ZsGreen+) colocalized with chondrocytes (COL2A1) at the fractured femur site in sections from Itm2a-CreER R26-Ai6 mice. Scale bars: 100 μm. (D) Representative 14 dpf confocal images of Itm2a lineage cells (ZsGreen+) colocalized with osteoblasts (OPN) at the fractured femur site in sections from Itm2a-CreER R26-Ai6 mice. Scale bars: 100 μm. (E) Representative 14 dpf confocal images of Itm2a lineage cells (ZsGreen+ ) colocalized with bone marrow stromal cells (LepR) at the fractured femur site in sections from Itm2a-CreER R26-Ai6 mice. Scale bars: 50 μm. (F) Percentage of Itm2a lineage cells (ZsGreen+) among COL2A1+ chondrocytes, OPN+ osteoblasts and LepR+ bone marrow stromal cells calculated from C, D, and E, respectively. n = 3 mice per condition. Data are presented as the mean ± SD. (G) Experimental design for tamoxifen induction, bone drill model, and tissue analysis. (H) Representative confocal images of femoral fracture sites in sections from Itm2a-CreER R26-Ai6 mice at 14 dpf after tamoxifen treatment. n = 4 mice per condition from 4 independent experiments. Scale bars: 100 μm. (I) Experimental design for tamoxifen induction, bone scratch model, and tissue analysis. (J) Representative confocal images of injury sites in tibia sections from Itm2a-CreER R26-Ai6 mice at 7 dpf and 14 dpf after tamoxifen administration. Scale bars: 100 μm. n = 4 mice per condition from 4 independent experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts